[ANO1, also known as transmembrane protein 16A (TMEM16A)] is a Ca 2ϩ -activated Cl Ϫ channel expressed in arterial myocytes that regulates membrane potential and contractility. Signaling mechanisms that control ANO1 activity in arterial myocytes are poorly understood. In cerebral artery myocytes, ANO1 channels are activated by local Ca 2ϩ signals generated by plasma membrane nonselective cation channels, but the molecular identity of these proteins is unclear. Arterial myocytes express several different nonselective cation channels, including multiple members of the transient receptor potential receptor (TRP) family. The goal of this study was to identify localized ion channels that control ANO1 currents in cerebral artery myocytes. Coimmunoprecipitation and immunofluorescence resonance energy transfer microscopy experiments indicate that ANO1 and canonical TRP 6 (TRPC6) channels are present in the same macromolecular complex and localize in close spatial proximity in the myocyte plasma membrane. In contrast, ANO1 is not near TRPC3, TRP melastatin 4, or inositol trisphosphate receptor 1 channels. Hyp9, a selective TRPC6 channel activator, stimulated Cl Ϫ currents in myocytes that were blocked by T16Ainh-A01, an ANO1 inhibitor, ANO1 knockdown using siRNA, and equimolar replacement of intracellular EGTA with BAPTA, a fast Ca 2ϩ chelator that abolishes local Ca 2ϩ signaling. Hyp9 constricted pressurized cerebral arteries, and this response was attenuated by T16Ainh-A01. In contrast, T16Ainh-A01 did not alter depolarization-induced (60 mM K ϩ ) vasoconstriction. , and Cl Ϫ , as well as nonselective cation channels (4,12,14,19). An understanding of the signaling processes that control the activity of these ion channels provides a better understanding of mechanisms that regulate arterial contractility. Anoctamin-1 [ANO1, also known as transmembrane protein 16A (TMEM16A)] is a recently described Ca 2ϩ -activated Cl Ϫ (Cl Ca ) channel expressed in arterial myocytes that regulates membrane potential and contractility (4). Mechanisms that control ANO1 activity in arterial myocytes are poorly understood but important to determine given the functional significance of this protein in the vasculature. ANO1 channel message and protein have been described in the vasculature, including rat cerebral, pulmonary, and carotid arteries, murine portal vein, retinal and skeletal muscle arterioles, and cultured rat pulmonary artery myocytes (7,15,23,30 (6,23,30). ANO1 knockdown reduced Cl Ca current density in rat cerebral and mesenteric arteries and cultured pulmonary artery myocytes (23, 30). T16Ainh-A01, an ANO1 inhibitor, relaxed methoxamine-contracted murine and human blood vessels (8). Selective ANO1 knockdown attenuated intravascular pressure-induced cerebral artery depolarization and vasoconstriction (5). Cell-specific knockout of ANO1 reduced Cl Ca currents in aortic and cerebral arteriole myocytes, agonist-induced vasoconstriction in retinal and skeletal muscle arterioles, and systemic blood pressure and attenuated hypertensio...